Antimitotic agents of natural origin

Curr Drug Targets. 2006 Mar;7(3):305-26. doi: 10.2174/138945006776054933.

Abstract

Antimitotic agents have been the most successful pharmacological agents for the treatment of cancer. The term "antimitotic agent" has traditionally been synonymous with tubulin-targeting compounds, but as a consequence of the large number of new compounds and mechanisms that have been identified recently, a much broader definition is currently needed. This review attempts to provide a broad overview of compounds and their cognate protein targets which result in a block in mitosis. Focus has been placed on agents that act directly on the mitotic machinery rather than on targets further upstream such as growth factor receptors.

Publication types

  • Review

MeSH terms

  • Actins / metabolism
  • Animals
  • Antimitotic Agents / classification
  • Antimitotic Agents / pharmacology*
  • Binding Sites / drug effects
  • Biological Products / classification
  • Biological Products / pharmacology*
  • Colchicine / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors
  • Humans
  • Kinesins / antagonists & inhibitors
  • Microtubule Proteins / antagonists & inhibitors
  • Phosphoric Monoester Hydrolases / antagonists & inhibitors
  • Phosphoric Monoester Hydrolases / genetics
  • Proteasome Inhibitors
  • Sulfhydryl Compounds / pharmacology
  • Topoisomerase Inhibitors
  • Tubulin / drug effects
  • Vinca Alkaloids / pharmacology

Substances

  • Actins
  • Antimitotic Agents
  • Biological Products
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Microtubule Proteins
  • Proteasome Inhibitors
  • Sulfhydryl Compounds
  • Topoisomerase Inhibitors
  • Tubulin
  • Vinca Alkaloids
  • Phosphoric Monoester Hydrolases
  • Kinesins
  • Colchicine